Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

BUY
$1.71 - $3.61 $528 - $1,115
309 New
309 $0
Q2 2022

Aug 04, 2022

SELL
$2.13 - $9.01 $506 - $2,144
-238 Closed
0 $0
Q1 2022

Apr 14, 2022

SELL
$6.28 - $15.59 $326 - $810
-52 Reduced 17.93%
238 $2,000
Q4 2021

Feb 14, 2022

BUY
$14.7 - $28.67 $514 - $1,003
35 Added 13.73%
290 $4,000
Q2 2021

Aug 04, 2021

SELL
$26.09 - $40.4 $2,765 - $4,282
-106 Reduced 29.36%
255 $9,000
Q1 2021

May 05, 2021

SELL
$33.06 - $56.93 $4,198 - $7,230
-127 Reduced 26.02%
361 $14,000
Q4 2020

Feb 04, 2021

BUY
$39.09 - $57.4 $19,075 - $28,011
488 New
488 $20,000
Q4 2019

Feb 07, 2020

SELL
$15.02 - $20.57 $180 - $246
-12 Closed
0 $0
Q3 2019

Nov 01, 2019

BUY
$18.85 - $27.5 $37 - $55
2 Added 20.0%
12 $0
Q2 2019

Aug 08, 2019

BUY
$17.37 - $26.27 $173 - $262
10 New
10 $0

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Glassman Wealth Services Portfolio

Follow Glassman Wealth Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Glassman Wealth Services with notifications on news.